Saccharomyces boulardii CNCM I-745 Supernatant Improves Markers of Gut Barrier Function and Inflammatory Response in Small Intestinal Organoids.

Filipe Rosa L, Gonda S, Roese N, Bischoff SC

Open source

DOI
10.3390/ph18081167
Published
2025 Aug 6
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph18081167,
  title = {Saccharomyces boulardii CNCM I-745 Supernatant Improves Markers of Gut Barrier Function and Inflammatory Response in Small Intestinal Organoids.},
  author = {Filipe Rosa L and Gonda S and Roese N and Bischoff SC},
  year = {2025},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph18081167},
  url = {https://doi.org/10.3390/ph18081167}
}

RIS

TY  - JOUR
TI  - Saccharomyces boulardii CNCM I-745 Supernatant Improves Markers of Gut Barrier Function and Inflammatory Response in Small Intestinal Organoids.
AU  - Filipe Rosa L
AU  - Gonda S
AU  - Roese N
AU  - Bischoff SC
PY  - 2025
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph18081167
UR  - https://doi.org/10.3390/ph18081167
ER  - 

APA

L, F. R., S, G., N, R., & SC, B. (2025). Saccharomyces boulardii CNCM I-745 Supernatant Improves Markers of Gut Barrier Function and Inflammatory Response in Small Intestinal Organoids.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph18081167

Source records